PART 10 U.K.Amendment of Part 10 (exceptions to requirement for marketing authorisations etc)

Amendment of regulation 169 (mixing of general sale medicinal products) U.K.

136.  In regulation 169(9)(a), [F1 for “marketing authorisation” substitute “UK marketing authorisation or EU marketing authorisation”] .

Textual Amendments

F1 Words in reg. 136 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 104

Commencement Information

I1 Reg. 136 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1